Patients' and physicians' awareness of clinical symptoms and disease severity in tuberous sclerosis complex

被引:0
|
作者
Sauter, Matthias [1 ]
Weber, Lea [2 ]
Jung, Dominik [2 ]
Weremko, Michael [3 ]
Bachmann, Dorothea [2 ]
Fischereder, Michael [4 ]
Bachmann, Hagen Sjard [2 ,3 ]
机构
[1] Klinikverbund Allgau, Robert Weixler Str 50, D-87439 Kempten, Germany
[2] Witten Herdecke Univ, Inst Pharmacol & Toxicol, Ctr Biomed Educ & Res ZBAF, Sch Med, Witten, Germany
[3] Univ Duisburg Essen, Univ Hosp Essen, Inst Pharmacogenet, Essen, Germany
[4] Klinikum Univ Munchen, Tuberose Sklerose Zent, Klin & Poliklin Radiol, Ziemssenstr 5, D-80336 Munich, Germany
关键词
Tuberous sclerosis complex; Disease severity; Surveillance; Disease awareness; Healthcare; EPILEPSY; SURVEILLANCE; INDIVIDUALS; GUIDELINES; CRITERIA;
D O I
10.1186/s13023-024-03118-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tuberous sclerosis complex (TSC) is a rare inherited disease with the potential to affect virtually every organ system. Clinical presentation is age- and partly sex-dependent and varies broadly with respect to disease manifestations including treatment-refractory epilepsy, intellectual disability and TSC-associated neuropsychiatric disorders, chronic kidney disease or progressive lung function decline. Given the complexity of this disease, multidisciplinary care in specialized TSC centres is recommended. We aimed to elucidate the state of knowledge of patients/caregivers and physicians on individual disease manifestations. We further examined whether the association to a TSC centre has an impact on the comprehensive consideration of potential disease manifestations. Therefore, a survey was performed in a cohort of German TSC patients and their physicians. Complete information was available for 94 patients with a median age of 18 years [range 1-55] and a sex distribution of 53.2% (male): 48.8% (female). Using almost identical questionnaires for patients/caregivers and their respective physician, there was a good correlation for disease assessments associated with relevant morbidity and mortality like epilepsy, renal angiomyolipoma, cardiac rhabdomyomas or intellectual disability. Correlation was moderate for several neuropsychiatric disorders and only poor for hypomelanotic macules, dental pits or retinal achromic patches. Estimation of overall disease severity using a numeric rating scale correlated highly significantly (Pearson correlation coefficient = 0.767; p < 0.001) between patients/caregivers and physicians. In general, physicians more likely quoted items as 'unknown' than patients (822 answers vs. 435 answers in the respective groups). Questionnaires completed by physicians who were associated with a specialized TSC centre declared a significantly lower proportion of items as unknown (mean 8.7% vs. 20.5%; p < 0.001). These findings indicate that patients treated by specialized TSC centres seem to obtain a more comprehensive surveillance. Furthermore, it shows that there were reasonable surveillance strategies in general and sufficient patient/caregiver interaction and education in the examined cohort. However, for the most prominent disease characteristics there was a good awareness within both the patients/caregivers and the physicians group.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Patients’ and physicians’ awareness of clinical symptoms and disease severity in tuberous sclerosis complex
    Matthias Sauter
    Lea Weber
    Dominik Jung
    Michael Weremko
    Dorothea Bachmann
    Michael Fischereder
    Hagen Sjard Bachmann
    Orphanet Journal of Rare Diseases, 19
  • [2] Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness
    Kingswood, J. Chris
    Belousova, Elena
    Benedik, Mirjana P.
    Carter, Tom
    Cottin, Vincent
    Curatolo, Paolo
    Dahlin, Maria
    D' Amato, Lisa
    d'Augeres, Guillaume Beaure
    de Vries, Petrus J.
    Ferreira, Jose C.
    Feucht, Martha
    Fladrowski, Carla
    Hertzberg, Christoph
    Jozwiak, Sergiusz
    Lawson, John A.
    Macaya, Alfons
    Marques, Ruben
    Nabbout, Rima
    O'Callaghan, Finbar
    Qin, Jiong
    Sander, Valentin
    Sauter, Matthias
    Shah, Seema
    Takahashi, Yukitoshi
    Touraine, Renaud
    Youroukos, Sotiris
    Zonnenberg, Bernard
    Jansen, Anna C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (03) : 502 - 508
  • [3] Clinical symptoms of tuberous sclerosis complex in patients with an identical TSC2 mutation
    Rok, P
    Kasprzyk-Obara, J
    Dománska-Pakiela, D
    Józwiak, S
    MEDICAL SCIENCE MONITOR, 2005, 11 (05): : CR230 - CR234
  • [4] Genetic Modifiers of Disease Severity in Tuberous Sclerosis Complex
    Sanchez-Castillo, M.
    Rangasamy, S.
    Ramsey, K.
    Sekar, S.
    Adkins, J.
    Cuyugan, L.
    Monheim-Janss, C.
    Sankaramoorthy, A.
    Kaneshamoorthy, S.
    Swaminathan, P.
    Aziz, A-M
    Narayanan, V
    ANNALS OF NEUROLOGY, 2023, 94 : S107 - S107
  • [5] Tuberous sclerosis complex: A clinical diagnosis in Ethiopian patients
    Sisay, Belete
    Tadesse, Abilo
    Gelaw, Abebe
    Getahun, Desalew
    Mulat, Biruk
    Kebede, Weynishet
    Gebrewold, Yonathan
    MEDICINE, 2024, 103 (06) : E37135
  • [6] SURVEILLANCE AND MANAGEMENT OF PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX
    Fogarasi, Andras
    Gyorsok, Zsuzsanna
    Bodo, Timea
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2017, 70 (3-4): : 97 - 103
  • [7] Characteristics and the clinical course of epilepsy in patients with tuberous sclerosis complex
    Saltik, Sema
    Karatoprak, Elif Yuksel
    Tasel, Bulent
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2013, 48 (02): : 123 - 130
  • [8] Epilepsy severity mediates association between mutation type and ADHD symptoms in tuberous sclerosis complex
    Tye, Charlotte
    McEwen, Fiona S.
    Liang, Holan
    Woodhouse, Emma
    Underwood, Lisa
    Shephard, Elizabeth
    Barker, Edward D.
    Sheerin, Fintan
    Higgins, Nicholas
    Steenbruggen, Juul
    Bolton, Patrick
    EPILEPSIA, 2023, 64 (03) : E30 - E35
  • [9] Severity of manifestations in tuberous sclerosis complex in relation to genotype
    Kothare, Sanjeev V.
    Singh, Kanwaljit
    Chalifoux, Jason R.
    Staley, Brigid A.
    Weiner, Howard L.
    Menzer, Kimberly
    Devinsky, Orrin
    EPILEPSIA, 2014, 55 (07) : 1025 - 1029
  • [10] TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex
    Kingswood, J. Chris
    Belousova, Elena
    Benedik, Mirjana P.
    Budde, Klemens
    Carter, Tom
    Cottin, Vincent
    Curatolo, Paolo
    Dahlin, Maria
    D'Amato, Lisa
    d'Augeres, Guillaume B.
    de Vries, Petrus J.
    Ferreira, Jose C.
    Feucht, Martha
    Fladrowski, Carla
    Hertzberg, Christoph
    Jozwiak, Sergiusz
    Lawson, John A.
    Macaya, Alfons
    Marques, Ruben
    Nabbout, Rima
    O'Callaghan, Finbar
    Qin, Jiong
    Sander, Valentin
    Sauter, Matthias
    Shah, Seema
    Takahashi, Yukitoshi
    Touraine, Renaud
    Youroukos, Sotiris
    Zonnenberg, Bernard
    Jansen, Anna C.
    FRONTIERS IN NEUROLOGY, 2021, 12